A Phase 1, First-in-Human Study of CND319 in Healthy Participants and Patients With Rheumatic Diseases

Clinical trial NCT07712939 · RECRUITING

Trial details

NCT number: NCT07712939
Sponsor: Candid Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants Study Rheumatoid Arthritis Sjogren's Syndrome

Start date: 2026-07-20
Primary completion: 2028-03-31
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.